Medical Properties Trust issues $2.5 billion in secured notes

Medical Properties Trust, Inc. (NYSE:MPW), a real estate investment trust (REIT) specializing in hospital facilities, has entered into a significant financial transaction involving the issuance of senior secured notes. Currently trading at $5.02, the company has shown strong momentum with a 25% return year-to-date, according to InvestingPro data. While the company maintains a 21-year track record of consecutive dividend payments, analysts anticipate challenges ahead with projected negative earnings for the year. On February 13, 2025, the company, through its operating partnership MPT Operating Partnership, L.P., and its subsidiary MPT Finance Corporation, closed an offering of $1.5 billion in 8.500% Senior Secured Notes due 2032 and €1 billion in 7.000% Senior Secured Notes due 2032.

This move, exempt from the Securities Act of 1933 registration requirements, targeted "qualified institutional buyers" in the United States and non-U.S. persons internationally. The notes are guaranteed by Medical Properties Trust and its subsidiaries and are secured by first-priority liens on equity of the company’s subsidiaries that own or ground lease a diversified pool of 169 properties across the U.S., the U.K., and Germany.

Interest payments on the notes are scheduled semi-annually with the first payment due on August 15, 2025. The notes will mature on February 15, 2032, but the company has the option to redeem them before February 15, 2028, at a "make-whole" redemption price or at a decreasing premium after this date. Additionally, the company may redeem up to 40% of the notes before February 15, 2028, using proceeds from equity offerings.

The indenture governing the notes imposes certain restrictions on the company and its subsidiaries, such as limitations on incurring additional debt, paying dividends, and entering into transactions with affiliates, among others. These covenants are subject to exceptions and qualifications as detailed in the indenture. InvestingPro analysis shows the company maintains a healthy current ratio of 5.8, indicating strong liquidity with assets well exceeding short-term obligations.

Concurrently, Medical Properties Trust amended its existing credit facility, removing certain financial covenants and modifying others to align with the notes’ definitions. The amendment also extended the maturity of the revolving credit facility to June 30, 2027, and reset the interest rate to SOFR plus 2.25%.

The company’s credit agreement, as amended, is now secured and guaranteed on par with the new notes and includes provisions for managing the collateral, which is subject to maintenance of specific coverage tests.

The information disclosed here is based on a press release statement and is intended to provide investors with relevant financial details of Medical Properties Trust’s recent strategic financing activities. With the company’s next earnings report due on February 20, 2025, investors seeking deeper insights can access comprehensive analysis through InvestingPro, which offers exclusive access to over 30 additional financial metrics and expert insights for MPW, including detailed Fair Value analysis and growth projections.

In other recent news, Medical Properties Trust has secured a substantial $2.5 billion through senior secured notes. This financing deal was achieved through the issuance of $1.5 billion in 8.500% senior secured notes and €1 billion in 7.000% senior secured notes, both maturing in 2032. The notes, guaranteed by Medical Properties Trust and certain subsidiaries, are secured by a diversified pool of 169 properties across the U.S., the U.K., and Germany.

The company has also amended its existing credit agreement, extending the maturity of the revolving credit facility to June 30, 2027, and introducing new conditions related to secured leverage and collateral coverage tests. These strategic financial maneuvers are designed to provide the company with increased financial flexibility and support its growth strategy.

In addition, Medical Properties Trust has settled a defamation lawsuit with Viceroy Research LLC, the specifics of which remain confidential. Meanwhile, Truist Securities has revised its price target on shares of Medical Properties Trust to $4.00, maintaining a Hold rating on the stock. The firm cites concerns over the company’s capital allocation and risk management practices.

Lastly, the company’s tenant, Prospect Medical (TASE:PMCN) Group, has initiated a Chapter 11 restructuring, which has resulted in Medical Properties Trust recognizing all revenues from Prospect using cash-basis accounting since 2023. These are the recent developments for Medical Properties Trust.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.